In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Lumentum's current price exceeds its PERT-weighted fair value by 25.3%, indicating potential overvaluation despite high confidence in the valuation. The DCF analysis shows negative mid-values, signaling weak profitability and growth reflected in a near-zero financial health score. Absence of downside risk in Monte Carlo scenarios contrasts with poor profitability, suggesting risk concentrated in earnings sustainability.